Works by Karasik, Avraham


Results: 71
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Pharmacologic Treatment of Type 2 Diabetes in the U.S., Sweden, and Israel.

    Published in:
    Diabetes Care, 2022, v. 45, n. 12, p. 2926, doi. 10.2337/dc22-1253
    By:
    • Lyu, Beini;
    • Sang, Yingying;
    • Selvin, Elizabeth;
    • Chang, Alex R.;
    • Alexander, G. Caleb;
    • Cohen, Cheli Melzer;
    • Coresh, Josef;
    • Shalev, Varda;
    • Chodick, Gabriel;
    • Karasik, Avraham;
    • Carrero, Juan-Jesus;
    • Fu, Edouard L.;
    • Xu, Yang;
    • Grams, Morgan E.;
    • Shin, Jung-Im
    Publication type:
    Article
    10

    Cognitive Function and the Risk for Diabetes Among Young Men.

    Published in:
    Diabetes Care, 2014, v. 37, n. 11, p. 2982, doi. 10.2337/dc14-0715
    By:
    • Twig, Gilad;
    • Gluzman, Israel;
    • Tirosh, Amir;
    • Gerstein, Hertzel C.;
    • Yaniv, Gal;
    • Afek, Arnon;
    • Derazne, Estela;
    • Tzur, Dorit;
    • Karasik, Avraham;
    • Gordon, Barak;
    • Fruchter, Eyal;
    • Lubin, Gadi;
    • Rudich, Assaf;
    • Cukierman-Yaffe, Tali
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19

    The STOP-NIDDM Trial.

    Published in:
    Diabetes Care, 1998, v. 21, n. 10, p. 1720, doi. 10.2337/diacare.21.10.1720
    By:
    • Chiasson, Jean-Louis;
    • Gomis, Ramon;
    • Hanefeld, Markolf;
    • Josse, Robert G.;
    • Karasik, Avraham;
    • Laakso, Markku
    Publication type:
    Article
    20

    Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs.

    Published in:
    2019
    By:
    • Schernthaner, Guntram;
    • Karasik, Avraham;
    • Abraitienė, Agnė;
    • Ametov, Alexander S.;
    • Gaàl, Zsolt;
    • Gumprecht, Janusz;
    • Janež, Andrej;
    • Kaser, Susanne;
    • Lalić, Katarina;
    • Mankovsky, Boris N.;
    • Moshkovich, Evgeny;
    • Past, Marju;
    • Prázný, Martin;
    • Radulian, Gabriela;
    • Smirčić Duvnjak, Lea;
    • Tkáč, Ivan;
    • Trušinskis, Kārlis
    Publication type:
    Editorial
    21
    22
    23
    24
    25
    26

    127-LB: Effectiveness and Safety of Empagliflozin in Routine Care in Europe and East Asia: Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study.

    Published in:
    Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-127-LB
    By:
    • KARASIK, AVRAHAM;
    • LANZINGER, STEFANIE;
    • TAN, ELISE C.H.;
    • YABE, DAISUKE;
    • KIM, DAE JUNG;
    • SHEU, WAYNE H-H;
    • COHEN, CHELI MELZER;
    • HOLL, REINHARD W.;
    • HA, KYOUNG HWA;
    • NYSTROM, THOMAS;
    • NISKANEN, LEO K.;
    • JENSEN, MAJKEN LINNEMANN;
    • KYAW, MOE H.;
    • NUNEZ, JULIO
    Publication type:
    Article
    27
    28
    29
    30
    31
    32

    Low Dose ACTH Test--a Word of Caution.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 1996, v. 81, n. 8, p. 3129, doi. 10.1210/jcem.81.8.8768887
    By:
    • Cohen, Ohad;
    • Sidi, Yechezkel;
    • Barazin, Meir;
    • Karasik, Avraham
    Publication type:
    Article
    33
    34
    35
    36

    Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data.

    Published in:
    Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01345-z
    By:
    • Khunti, Kamlesh;
    • Kosiborod, Mikhail;
    • Kim, Dae Jung;
    • Kohsaka, Shun;
    • Lam, Carolyn S. P.;
    • Goh, Su-Yen;
    • Chiang, Chern-En;
    • Shaw, Jonathan E.;
    • Cavender, Matthew A.;
    • Tangri, Navdeep;
    • Franch-Nadal, Josep;
    • Holl, Reinhard W.;
    • Jørgensen, Marit E.;
    • Norhammar, Anna;
    • Eriksson, Johan G.;
    • Zaccardi, Francesco;
    • Karasik, Avraham;
    • Magliano, Dianna J.;
    • Thuresson, Marcus;
    • Chen, Hungta
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43

    Familial prolactinoma.

    Published in:
    Clinical Endocrinology, 1995, v. 42, n. 5, p. 483, doi. 10.1111/j.1365-2265.1995.tb02666.x
    By:
    • Berezin, Meir;
    • Karasik, Avraham
    Publication type:
    Article
    44
    45

    Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.

    Published in:
    Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01963-9
    By:
    • Vistisen, Dorte;
    • Carstensen, Bendix;
    • Elisabetta, Patorno;
    • Lanzinger, Stefanie;
    • Tan, Elise Chia-Hui;
    • Yabe, Daisuke;
    • Kim, Dae Jung;
    • Sheu, Wayne H.-H.;
    • Melzer-Cohen, Cheli;
    • Holl, Reinhard W.;
    • Núñez, Júlio;
    • Ha, Kyoung Hwa;
    • Halvorsen, Sigrun;
    • Langslet, Gisle;
    • Karasik, Avraham;
    • Nyström, Thomas;
    • Niskanen, Leo;
    • Guleria, Sonia;
    • Klement, Riho;
    • Carrasco, Marc
    Publication type:
    Article
    46
    47
    48
    49
    50